ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 53 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $718 | -28.2% | 6,191 | -2.1% | 0.00% | – |
| Q4 2022 | $1,000 | -50.0% | 6,327 | -37.9% | 0.00% | – |
| Q3 2022 | $2,000 | -60.0% | 10,191 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 10,191 | -19.7% | 0.00% | – |
| Q1 2022 | $7,000 | -12.5% | 12,691 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -27.3% | 12,691 | +8.7% | 0.00% | – |
| Q3 2021 | $11,000 | +10.0% | 11,671 | +27.3% | 0.00% | – |
| Q2 2021 | $10,000 | +100.0% | 9,171 | +77.4% | 0.00% | – |
| Q1 2021 | $5,000 | -28.6% | 5,171 | -63.5% | 0.00% | – |
| Q4 2020 | $7,000 | +75.0% | 14,171 | +168.8% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 5,271 | -35.5% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 8,171 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 8,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
| Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
| Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
| Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
| Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
| Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
| Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
| RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |